A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

Who May Qualify: - Subjects are prospectively planned and intended to be treated with the FARAPULSE™ Pulsed Field Ablation system for cardiac tissue ablation, per physician's medical judgement, and as per hospitals' standard of care - Subjects who are willing and capable of providing willing to sign a consent form - Subjects who are willing and capable of participating to this Registry at an approved clinical investigational center - Subjects whose age is 18 years or above, or who are of legal age to give willing to sign a consent form specific to state and national law - Subjects are planned to undergo an ablation procedure whereby the FARAWAVE NAV PF Ablation Catheter is used in conjunction with the OPAL HDx Mapping System. Who Should NOT Join This Trial: - Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study. Exceptions are when the subject is participating in a mandatory governmental registry, or a purely observational registry, that do not interfere with the current study Always talk to your doctor about whether this trial is right for you.